» Articles » PMID: 17205569

Assessing Immunophenotyping Performance: Proficiency-validation for Adopting Improved Flow Cytometry Methods

Overview
Specialty Cell Biology
Date 2007 Jan 6
PMID 17205569
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The continuous improvement and evolution of immune cell phenotyping requires periodic upgrading of laboratory methods and technology. Flow cytometry laboratories that are participating in research protocols sponsored by the NIAID are required to perform "switch" studies to validate performance before methods for T-cell subset analysis can be changed.

Methods: Switch studies were conducted among the four flow cytometry laboratories of the Multicenter AIDS Cohort Study (MACS), comparing a 2-color, lyse-wash method and a newer, 3-color, lyse no-wash method. Two of the laboratories twice failed to satisfy the criteria for acceptable differences from the previous method. Rather than repeating more switch studies, these laboratories were allowed to adopt the 3-color, lyse no-wash method. To evaluate the impact of the switch to the new method at these two sites, their results with the new method were evaluated within the context of all laboratories participating in the NIH-NIAID-Division of AIDS Immunology Quality Assurance (IQA) proficiency-testing program.

Results: Laboratory performance at these two sites substantially improved relative to the IQA standard test results. Variation across the four MACS sites and across replicate samples was also reduced.

Conclusions: Although switch studies are the conventional method for assessing comparability of laboratory methods, two alternatives to the requirement of repeating failed switch studies should be considered: (1) test the new method and assess performance on the proficiency testing reference panel, and (2) prior to adoption of the new methods, use both the old and the new method on the reference panel samples and demonstrate that performance with the new method is better according to standard statistical procedures. These alternatives may help some laboratories' transition to a new and superior methodology more quickly than if they are required to attempt multiple, serial switch studies.

Citing Articles

Decreased but persistent epigenetic age acceleration is associated with changes in T-cell subsets after initiation of highly active antiretroviral therapy in persons living with HIV.

Sehl M, Breen E, Shih R, Li F, Zhang J, Langfelder P Front Bioinform. 2024; 4:1356509.

PMID: 38855141 PMC: 11157435. DOI: 10.3389/fbinf.2024.1356509.


Vision Problems As a Contributor to Lower Engagement in Care Among Aging Men Living with HIV.

Abraham A, Tong W, Stosor V, Friedman M, Detels R, Plankey M Ophthalmic Epidemiol. 2024; 32(2):143-152.

PMID: 38771594 PMC: 11579247. DOI: 10.1080/09286586.2024.2346894.


Shorter total sleep time is associated with lower CD4+/CD8+ T cell ratios in virally suppressed men with HIV.

Borker P, Macatangay B, Margolick J, Punjabi N, Rinaldo C, Stosor V Sleep Adv. 2024; 5(1):zpae001.

PMID: 38420256 PMC: 10901437. DOI: 10.1093/sleepadvances/zpae001.


Accelerated aging with HIV begins at the time of initial HIV infection.

Breen E, Sehl M, Shih R, Langfelder P, Wang R, Horvath S iScience. 2022; 25(7):104488.

PMID: 35880029 PMC: 9308149. DOI: 10.1016/j.isci.2022.104488.


Marijuana use and pneumonia risk in a cohort of HIV-infected and HIV-uninfected men.

Quint J, Tashkin D, McKay H, Plankey M, Stosor V, Friedman M Ann Epidemiol. 2020; 52:64-70.e2.

PMID: 32763342 PMC: 7725997. DOI: 10.1016/j.annepidem.2020.07.018.


References
1.
Schnizlein-Bick C, Mandy F, OGorman M, Paxton H, Nicholson J, Hultin L . Use of CD45 gating in three and four-color flow cytometric immunophenotyping: guideline from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry. 2002; 50(2):46-52. DOI: 10.1002/cyto.10073. View

2.
Gelman R, Wilkening C . Analyses of quality assessment studies using CD45 for gating lymphocytes for CD3(+)4(+)%. Cytometry. 2000; 42(1):1-4. DOI: 10.1002/(sici)1097-0320(20000215)42:1<1::aid-cyto1>3.0.co;2-a. View

3.
Gelman R, Cheng S, Kidd P, Waxdal M, Kagan J . Assessment of the effects of instrumentation, monoclonal antibody, and fluorochrome on flow cytometric immunophenotyping: a report based on 2 years of the NIAID DAIDS flow cytometry quality assessment program. Clin Immunol Immunopathol. 1993; 66(2):150-62. DOI: 10.1006/clin.1993.1019. View

4.
Giorgi J, Landay A . HIV infection: diagnosis and disease progression evaluation. Methods Cell Biol. 1994; 42 Pt B:437-55. DOI: 10.1016/s0091-679x(08)61089-4. View

5.
Schenker E, Hultin L, Bauer K, Ferbas J, Margolick J, Giorgi J . Evaluation of a dual-color flow cytometry immunophenotyping panel in a multicenter quality assurance program. Cytometry. 1993; 14(3):307-17. DOI: 10.1002/cyto.990140311. View